Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research.
Purity:
>97.0%
CAS Number:
[1796566-95-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted